Wealth Enhancement Advisory Services LLC Has $9.44 Million Stock Holdings in Axon Enterprise, Inc $AXON

Wealth Enhancement Advisory Services LLC cut its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 7.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,866 shares of the biotechnology company’s stock after selling 937 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Axon Enterprise were worth $9,439,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of AXON. Mn Services Vermogensbeheer B.V. lifted its stake in shares of Axon Enterprise by 3.0% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 27,200 shares of the biotechnology company’s stock valued at $22,520,000 after buying an additional 800 shares during the period. Wedmont Private Capital increased its holdings in shares of Axon Enterprise by 4.8% during the second quarter. Wedmont Private Capital now owns 865 shares of the biotechnology company’s stock worth $697,000 after buying an additional 40 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in shares of Axon Enterprise by 8.3% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 9,029 shares of the biotechnology company’s stock valued at $7,475,000 after purchasing an additional 692 shares during the last quarter. Sivia Capital Partners LLC bought a new stake in shares of Axon Enterprise during the second quarter valued at approximately $284,000. Finally, Dynamic Advisor Solutions LLC grew its stake in shares of Axon Enterprise by 76.7% during the second quarter. Dynamic Advisor Solutions LLC now owns 5,511 shares of the biotechnology company’s stock valued at $4,563,000 after purchasing an additional 2,393 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Monday, September 8th. The shares were sold at an average price of $743.64, for a total transaction of $7,436,400.00. Following the transaction, the chief executive officer directly owned 3,043,982 shares of the company’s stock, valued at $2,263,626,774.48. This represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeri Williams sold 100 shares of the stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $752.54, for a total transaction of $75,254.00. Following the transaction, the director directly owned 1,416 shares in the company, valued at approximately $1,065,596.64. This represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 44,932 shares of company stock worth $34,408,816. Corporate insiders own 5.70% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Bank of America raised their price objective on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. UBS Group restated a “neutral” rating and set a $840.00 price objective (up from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. JMP Securities raised their price objective on shares of Axon Enterprise from $725.00 to $825.00 and gave the stock a “market outperform” rating in a report on Tuesday, July 22nd. Raymond James Financial reiterated an “outperform” rating and issued a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, Wolfe Research assumed coverage on shares of Axon Enterprise in a research report on Monday, July 7th. They issued an “outperform” rating for the company. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $837.69.

Axon Enterprise Trading Up 0.2%

Shares of NASDAQ AXON opened at $775.92 on Tuesday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a 52-week low of $388.36 and a 52-week high of $885.91. The firm has a 50 day moving average price of $760.48 and a two-hundred day moving average price of $698.43. The stock has a market cap of $60.91 billion, a P/E ratio of 191.59, a price-to-earnings-growth ratio of 28.43 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm had revenue of $668.54 million during the quarter, compared to analysts’ expectations of $641.77 million. During the same period in the prior year, the company posted $1.20 EPS. The company’s revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, equities analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.